Stockscreener 앱 받기
75.19
0.19%
0.14
시간 외 거래:
75.19
전일 마감가:
$75.05
열려 있는:
$75.06
하루 거래량:
781.57K
Relative Volume:
0.23
시가총액:
$16.79B
수익:
$4.04B
순이익/손실:
$557.10M
주가수익비율:
31.20
EPS:
2.4102
순현금흐름:
$916.70M
1주 성능:
+0.28%
1개월 성능:
+0.93%
6개월 성능:
+13.07%
1년 성능:
+5.87%
1일 변동 폭
$75.06
$75.24
1주일 범위
$74.86
$75.31
52주 변동 폭
$51.90
$75.34
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.19 | 16.75B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
528.82 | 185.75B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.37 | 57.49B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.79 | 39.44B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.84 | 38.28B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
255.55 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-12 | 다운그레이드 | Argus | Buy → Hold |
| 2026-01-05 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-11-21 | 다운그레이드 | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-08-18 | 업그레이드 | Argus | Hold → Buy |
| 2025-08-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-27 | 재확인 | Needham | Hold |
| 2025-03-03 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | 다운그레이드 | Needham | Buy → Hold |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
Stay Ahead of the Game With Hologic (HOLX) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
The Truth About Hologic Inc: Why This ‘Boring’ Stock Could Be a Silent Game-Changer - AD HOC NEWS
Universal Beteiligungs und Servicegesellschaft mbH Raises Holdings in Hologic, Inc. $HOLX - MarketBeat
Hologic Faces Del. Class Suit Over $18.3B Sale Disclosures - Law360
Anatomic Pathology Market Research: Global and Regional Insights, Competition, Forecast and Opportunities, 2025-2033 | Astute Analytica - GlobeNewswire Inc.
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Finviz
Hologic Q1 Earnings Preview: How Should You Play the Stock Now? - Finviz
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? - Finviz
Here's Why Hologic (HOLX) is a Strong Momentum Stock - Yahoo Finance
Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings? - The Globe and Mail
(HOLX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Hologic, Inc. (HOLX): A Bear Case Theory - Finviz
Hologic, Inc. (HOLX): A bear case theory - MSN
Aug Shorts: Is Hologic Inc attractive for institutional investors2025 Key Highlights & Advanced Technical Analysis Signals - baoquankhu1.vn
HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now? - Yahoo Finance
3D Imaging Teleradiology Service Market Hits New High | Major - openPR.com
Is Hologic Inc. stock a buy or sellJuly 2025 Trends & Long-Term Growth Stock Strategies - bollywoodhelpline.com
Is It Time To Reassess Hologic (HOLX) After Recent Valuation Signals - Yahoo Finance
Hologic says 2026 CVR is more challenging with stopped shipment of product - MSN
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com
'Good Morning Gorgeous': Hologic, Mary J. Blige Team To Tout Well Woman Exams 08/22/2022 - MediaPost
How low can spreads go? Hologic’s mega LBO tests the limit - PitchBook
Hologic wraps massive syndicated LBO loan - PitchBook
Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening - The Globe and Mail
61,780 Shares in Hologic, Inc. $HOLX Purchased by Campbell & CO Investment Adviser LLC - MarketBeat
Press Release: Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - 富途资讯
As Blackstone and TPG pursue Hologic deal, Q1 results arrive Jan. 29 - Stock Titan
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - Hologic
About Us - FinancialContent
Hologic’s $8.5 Billion LBO Loan Costs Tighten on Strong Demand - Bloomberg.com
What you need to know ahead of Hologic's earnings release - MSN
Hologic’s $8.5 billion LBO loan costs tighten on strong demandBloomberg News - TradingView — Track All Markets
Aug Macro: What are analysts price targets for Hologic IncEarnings Risk Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Nordea Investment Management AB Increases Stake in Hologic, Inc. $HOLX - MarketBeat
Skin Rejuvenation Devices Market Set for Rapid Expansion - openPR.com
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening - GuruFocus
Body Contouring Market Top Key Players 20262035: Allergan - openPR.com
How Recent Analyst Moves Are Rewriting The Story For Hologic (NasdaqGS:HOLX) - Yahoo Finance
Argus Research Downgrades Hologic (HOLX) to Hold | HOLX Stock Ne - GuruFocus
Hologic (NASDAQ:HOLX) Downgraded by Argus to "Hold" - MarketBeat
Blackstone (BX) Involved in Hologic Acquisition Deal - GuruFocus
SG Americas Securities LLC Grows Position in Hologic, Inc. $HOLX - MarketBeat
Is Hologic Inc. stock affected by interest rate hikesPortfolio Update Summary & Daily Risk Controlled Trade Plans - Улправда
(HOLX) Risk Channels and Responsive Allocation - Stock Traders Daily
What market sentiment indicators show for Hologic Inc. (HO1) stock2025 Volatility Report & Growth Oriented Trading Recommendations - ulpravda.ru
Why Hologic Inc. stock is recommended by analystsJuly 2025 Big Picture & Fast Gain Stock Tips - ulpravda.ru
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.88%
0.50%
자본화:
|
볼륨(24시간):